Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.359 EUR | +21.69% | +8.79% | -0.28% |
Apr. 17 | Intrasense: an innovative solution for cancer monitoring | CF |
Apr. 09 | Guerbet: CE certificate for a platform | CF |
Sales 2022 | 3.79M 4.06M | Sales 2023 | 3.3M 3.54M | Capitalization | 18.8M 20.13M |
---|---|---|---|---|---|
Net income 2022 | -3M -3.21M | Net income 2023 | -3M -3.21M | EV / Sales 2022 | 2.85 x |
Net Debt 2022 | 650K 696K | Net cash position 2023 | 3.06M 3.28M | EV / Sales 2023 | 4.76 x |
P/E ratio 2022 |
-2.97
x | P/E ratio 2023 |
-5.16
x | Employees | 74 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 44.57% |
1 day | +21.69% | ||
1 week | +8.79% | ||
Current month | +56.09% | ||
1 month | +56.09% | ||
3 months | +6.21% | ||
6 months | -16.51% | ||
Current year | -0.28% |
Managers | Title | Age | Since |
---|---|---|---|
Nicolas Reymond
CEO | Chief Executive Officer | 42 | 18-02-11 |
Julien Coste
DFI | Director of Finance/CFO | - | - |
Frédéric Champ
CTO | Chief Tech/Sci/R&D Officer | - | 22-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michèle Lesieur
CHM | Chairman | 65 | 20-10-07 |
Patrice Rullier
BRD | Director/Board Member | 63 | 19-03-14 |
Nicolas Reymond
CEO | Chief Executive Officer | 42 | 18-02-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.359 | +21.69% | 148,281 |
24-04-29 | 0.295 | -6.65% | 75,232 |
24-04-26 | 0.316 | -3.66% | 49,262 |
24-04-25 | 0.328 | -1.20% | 45,402 |
24-04-24 | 0.332 | +1.84% | 12,525 |
Real-time Euronext Paris, April 30, 2024 at 11:19 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-0.28% | 20.04M | |
+8.33% | 217B | |
+6.72% | 183B | |
+10.18% | 131B | |
+24.91% | 106B | |
-0.95% | 62.16B | |
+10.56% | 51.02B | |
+4.81% | 50.89B | |
-0.24% | 40.16B | |
+1.22% | 34.79B |
- Stock Market
- Equities
- ALINS Stock